Elanco Animal Health (ELAN) Total Current Liabilities (2017 - 2026)
Elanco Animal Health's (ELAN) quarterly Total Current Liabilities came in at $1.9 billion in Q2 2026, up 33.05% year-over-year from $1.4 billion in Q2 2025, and up 11.43% quarter-over-quarter from $1.7 billion in Q1 2026.
Analysis
Elanco Animal Health (ELAN) Total Current Liabilities (2017 - 2026) Analysis & Trends
Elanco Animal Health has disclosed Total Current Liabilities across 10 years of filings, most recently posting $1.9 billion for Q2 2026.
- In Q2 2026, Total Current Liabilities rose 33.05% year-over-year to $1.9 billion; the TTM figure through Jun 2026 stood at $1.9 billion (up 33.05% YoY), while the FY2025 annual figure was $1.6 billion, up 21.44% from the prior year.
- Total Current Liabilities came in at $1.9 billion for Q2 2026 at Elanco Animal Health, up from $1.7 billion in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $1.9 billion in Q2 2026 to a low of $1.2 billion in Q1 2024.
- Average Total Current Liabilities over 5 years is $1.4 billion, with a median of $1.4 billion recorded in 2022.
- Year-over-year, Total Current Liabilities tumbled 35.74% in 2022 and soared 33.05% in 2026.
- Over 5 years, Total Current Liabilities stood at $1.7 billion in 2022, then retreated by 27.09% to $1.2 billion in 2023, then gained by 5.96% to $1.3 billion in 2024, then grew by 21.44% to $1.6 billion in 2025, then gained by 15.97% to $1.9 billion in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $1.9 billion in Q2 2026, $1.7 billion in Q1 2026, and $1.6 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.53 Bn | 40.34 Bn | 779.09 Mn | 1.29 Bn |
| 2 | Zoetis | 30.65 Bn | 28.97 Bn | 1.05 Bn | 2.06 Bn |
| 3 | Elanco Animal Health | 11.81 Bn | 11.28 Bn | 798.00 Mn | 1.85 Bn |
| 4 | Phibro Animal Health | 1.51 Bn | 1.42 Bn | 134.40 Mn | 316.47 Mn |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn | 4.44 Mn |
| 6 | Zhengye Biotechnology Holding | 76.23 Mn | 69.14 Mn | - | 16.99 Mn |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | 7,791.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.85 Bn |
| Mar 31, 2026 | 1.66 Bn |
| Dec 31, 2025 | 1.60 Bn |
| Sep 30, 2025 | 1.46 Bn |
| Jun 30, 2025 | 1.39 Bn |
| Mar 31, 2025 | 1.27 Bn |
| Dec 31, 2024 | 1.32 Bn |
| Sep 30, 2024 | 1.32 Bn |
| Jun 30, 2024 | 1.37 Bn |
| Mar 31, 2024 | 1.23 Bn |
| Dec 31, 2023 | 1.24 Bn |
| Sep 30, 2023 | 1.27 Bn |
| Jun 30, 2023 | 1.28 Bn |
| Mar 31, 2023 | 1.58 Bn |
| Dec 31, 2022 | 1.70 Bn |
| Sep 30, 2022 | 1.61 Bn |
| Jun 30, 2022 | 1.34 Bn |
| Mar 31, 2022 | 1.31 Bn |
| Dec 31, 2021 | 1.65 Bn |
| Sep 30, 2021 | 1.36 Bn |